Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Endocyte financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$70 K
FY, 2017
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 191.0K | 34.7M | 64.9M | 70.4M | 70.0K | 70.0K | 70.0K |
| Revenue growth, % | 8.5% | -99.9% | |||||
| General and administrative expense | 10.0M | 15.1M | 25.3M | 23.7M | 15.7M | 17.3M | 13.8M |
| Operating expense total | 38.8M | 50.7M | 83.2M | 65.3M | 42.0M | 44.8M | 39.6M |
| EBIT | (38.6M) | (16.0M) | (18.3M) | 5.0M | (42.0M) | (44.7M) | (56.1M) |
| EBIT margin, % | -20226.2% | -46.3% | -28.3% | 7.1% | -59961.3% | -63886.2% | -80151.5% |
| Interest income | 129.4K | 327.7K | 465.5K | 578.6K | |||
| Interest expense | 2.0M | 629.0K | 651.5K | 861.2K | 1.0M | ||
| Net Income | (40.5M) | (17.3M) | (18.0M) | 5.5M | (41.3M) | (43.9M) | (55.1M) |